FOR AUTHORS
Search
Search Results
Found 9 items.
-
The scientific targets: the myocardium, the vasculature and the body’s response to heart failure
Published: March 28, 20242197PDF: 74HTML: 14 -
Iron deficiency in heart failure with preserved ejection fraction: rationale and design of the FAIR-HFpEF trial
Published: December 27, 20231807pdf: 292HTML: 10 -
Detection of early heart failure with preserved ejection fraction in metabolic syndrome patients detected as part of a national screening program in middle aged subjects
Published: December 29, 20231006pdf: 90HTML: 1 -
Evolving targets for heart failure: the journey so far
Published: November 28, 20231503pdf: 121HTML: 4 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
Published: November 23, 2023707pdf: 121Supplementary Material: 19HTML: 19 -
Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378
Published: December 30, 20241259pdf: 407 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
Published: June 28, 20241397PDF: 393SUPPLEMENTARY MATERIAL: 260GRAPHICAL ABSTRACT: 237 -
Pulmonary artery pressure sensor device performance in patients with atrial fibrillation/flutter
Published: December 30, 20241072Pdf: 306APPENDIX: 317 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
Published: June 28, 20241746PDF: 472Conflict of interest: 256SUPPLEMENTARY MATERIAL: 234
1 - 9 of 9 items